Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Yiling Wanzhou International Pharmaceutical obtained Chinese approval for its tadalafil tablets, according to a Saturday filing with the Shenzhen bourse.
The drug is a PDE5 inhibitor, indicated for erectile dysfunction.